Payment & Shipping Terms | Supply Capacity |
Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Lestaurtinib
CAS 111358-88-4 Letatinib is a semi synthetic, oral, biologically effective receptor tyrosine kinase inhibitor, which has been shown to have therapeutic effects in the treatment of diseases such as acute myeloid leukemia, chronic myeloid leukemia and acute lymphocytic leukemia. Letatinib, a multi-target indole carbazole derivative, has been widely used in clinical trials to inhibit FLT3 autophosphorylation in vitro. A number of late stage trials are under way to study the drug in adult and child leukaemia.
We can customize according to customer's requirement
if you have any question pls mail us or call us.
